Tamil Nadu's first case of covid-19 Omicron BA. 4 sub lineage variant is a teenager and a part of a four-member family with no travel history and had taken two jabs of the vaccine against the virus.
The 19-year-old college student from neighbouring Chengalpattu district, who had contracted Omicron BA. 4 sub lineage variant has fully recovered and this strain has not spread to other parts of Tamil Nadu, state Health and Family Welfare Principal Secretary Dr J Radhakrishnan said on Monday.
The teenager, among the family of four who was infected with the contagion, did not have any travel history. Epidemiologically it has not been detected how this particular strain, infected her, he said.
"Probably, the strain could have been circulating around. Her's is the only case in the state. She has fully recovered," Dr Radhakrishnan told PTI.
Interestingly, her mother, aged 45, who along with her daughter developed a mild flu like illness on May 4, voluntarily underwent RT-PCR test at a private lab, and had BA.2 sub-lineage while her daughter had BA.4 variant. Both were caused by the Omicron variant ofRS CoV-2.
The BA.2 is the predominant variant reported in 73 percent of the samples sequenced for Whole Genomic Sequencing (WGS) of covid-19 samples in Tamil Nadu. The recent clusters in IIT Madras and Sri Sathya Sai Medical College were due to the BA.2 variant of Omicron.
"Both the mother and daughter self-quarantined and recovered in three days," Dr Radhakrishnan said and added that the government of India had announced that BA. 4 is not a cause of panic.
The girl's father and grandmother did not have symptoms. Three among this family residing in a gated community at Navalur, OMR, Chengalpattu district, had completed 2 doses of the vaccine while the grandmother had taken a single shot.
The samples of mother and daughter were sent to NEERI, Nagpur on May 13 for WGS and the results were obtained on May 19.
On Sunday, the IndianRS-CoV-2 Genomics Consortium (INSACOG) had said the teen had been found infected with the BA.4 sub-variant of the virus.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)